Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation

P Uhrin, D Wang, A Mocan, B Waltenberger… - Biotechnology …, 2018 - Elsevier
Many natural products have been so far tested regarding their potency to inhibit vascular
smooth muscle cell proliferation, a process involved in atherosclerosis, pulmonary …

Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways

D Wang, P Uhrin, A Mocan, B Waltenberger… - Biotechnology …, 2018 - Elsevier
Cardiovascular diseases are a major cause of human death worldwide. Excessive
proliferation of vascular smooth muscle cells contributes to the etiology of such diseases …

[HTML][HTML] Plant-derived products for treatment of vascular intima hyperplasia selectively inhibit vascular smooth muscle cell functions

K Xu, MK Al-Ani, X Pan, Q Chi, N Dong… - … and Alternative Medicine, 2018 - hindawi.com
Natural products are used widely for preventing intimal hyperplasia (IH), a common
cardiovascular disease. Four different cells initiate and progress IH, namely, vascular …

Pathways of proliferation: new targets to inhibit the growth of vascular smooth muscle cells

G Marsboom, SL Archer - Circulation research, 2008 - Am Heart Assoc
Excessive proliferation of vascular smooth muscle cells (VSMCs) contributes to the
pathogenesis of many cardiovascular diseases, including atherosclerosis and pulmonary …

New strategies to prevent restenosis

M Kester, P Waybill, M Kozak - American Journal of Cardiovascular Drugs, 2001 - Springer
Abstract The Holy Grail of cardiovascular pharmacology has been the search for an effective
therapy targeting restenosis after angioplasty and/or intra-arterial stenting. The failure of …

Anti-angiogenesis: a new potential strategy to inhibit restenosis

S Fuchs, Ran Kornowski, Martin B Leon … - International Journal …, 2001 - Taylor & Francis
Microvessels are an integral component of the neointima developing in response to the
acute vascular injury resulting from angioplasty. These vessels originate from the vasa …

Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases

A Rivard, V Andrés - 2000 - digital.csic.es
Atherosclerosis is the principal cause of myocardial infarction, stroke, and peripheral
vascular disease, accounting for nearly half of all mortality in developed countries. For …

Antiangiogenic compounds: well-established drugs versus emerging natural molecules

A Ribeiro, RMV Abreu, MM Dias, MF Barreiro… - Cancer Letters, 2018 - Elsevier
Angiogenesis is the natural and physiologic process of growing blood vessels from pre-
existing ones. Pathological angiogenesis occurs when the precise balance of all the …

High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation

SA Goel, LW Guo, B Wang, S Guo, D Roenneburg… - PloS one, 2014 - journals.plos.org
Intimal hyperplasia is the cause of the recurrent occlusive vascular disease (restenosis).
Drugs currently used to treat restenosis effectively inhibit smooth muscle cell (SMC) …

Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells

CM Matter, I Rozenberg, A Jaschko… - Journal of …, 2006 - journals.lww.com
Local strategies directed against vascular smooth muscle cell (VSMC) proliferation such as
drug-eluting stents reduce the occurrence of restenosis. However, these approaches may …